Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Vaccitech Plc ADR (VACC)

Vaccitech Plc ADR (VACC)
5.00 +0.51 (+11.36%) 11/07/23 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Mon, Nov 6th, 2023
Day Low
4.28
Day High
5.10
Open 4.60
Previous Close 4.49 4.49
Volume 165,300 165,300
Avg Vol 54,895 54,895
Stochastic %K 94.84% 94.84%
Weighted Alpha +52.70 +52.70
5-Day Change +0.76 (+17.92%) +0.76 (+17.92%)
52-Week Range 1.64 - 5.10 1.64 - 5.10
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 192,735
  • Shares Outstanding, K 38,547
  • Annual Sales, $ 44,700 K
  • Annual Income, $ 5,340 K
  • EBIT $ -66 M
  • EBITDA $ -62 M
  • 60-Month Beta -0.40
  • Price/Sales 3.87
  • Price/Cash Flow 19.30
  • Price/Book 0.88
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.43
  • Most Recent Earnings $-0.62 on 08/10/23
  • Next Earnings Date 11/09/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.62
  • Number of Estimates 2
  • High Estimate -0.54
  • Low Estimate -0.70
  • Prior Year 0.22
  • Growth Rate Est. (year over year) -381.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.04 +64.74%
on 10/24/23
Period Open: 3.39
5.10 -1.96%
on 11/06/23
+1.61 (+47.49%)
since 10/06/23
3-Month
1.64 +204.88%
on 09/25/23
Period Open: 2.27
5.10 -1.96%
on 11/06/23
+2.73 (+120.26%)
since 08/04/23
52-Week
1.64 +204.88%
on 09/25/23
Period Open: 2.65
5.10 -1.96%
on 11/06/23
+2.35 (+88.68%)
since 11/04/22

Most Recent Stories

More News
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END

BMY : 57.47 (+2.10%)
ONCY : 0.8184 (+3.46%)
ONC.TO : 1.18 (unch)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 3.45 (+2.99%)
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...

ONC.TO : 1.18 (unch)
ONCY : 0.8184 (+3.46%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 3.45 (+2.99%)
BMY : 57.47 (+2.10%)
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment

Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK Government’s...

VACC : 5.00 (+11.36%)
Canadian CPI, U.S. Home Sales Featured Next Week

Monday U.S. Featured Earnings PDD Holdings Inc. (NASDAQ:PDD) (Q4) Reported EPS of $1.00, ...

PDD : 104.19 (-1.31%)
FL : 20.84 (+1.91%)
RETA : 172.36 (+0.02%)
NKE : 72.63 (+2.53%)
TME : 11.17 (+3.62%)
ONON : 60.08 (+3.62%)
CTAS : 202.06 (+1.89%)
CHWY : 36.51 (-1.35%)
FUL : 62.83 (+1.19%)
ACN : 355.60 (+0.85%)
GIS : 60.33 (+1.17%)
DRI : 185.13 (+1.86%)
Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments

OXFORD, United Kingdom, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC) today announced its financial results for the second quarter ended...

VACC : 5.00 (+11.36%)
Vaccitech to Present at the William Blair Biotech Focus Conference 2022

OXFORD, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the...

VACC : 5.00 (+11.36%)
Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy and in combination with a single low dose of anti-PD-1

VTP-300 as a monotherapy and in combination with a single administration of low-dose nivolumab was administered, with no treatment-related serious adverse...

VACC : 5.00 (+11.36%)
Vaccitech to Present at the Jefferies Healthcare Conference

OXFORD, United Kingdom, June 06, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the...

VACC : 5.00 (+11.36%)
Arbutus and Vaccitech Dose First Patient in Phase 2a Clinical Trial Combining Therapies for the Treatment of Chronic Hepatitis B Virus

Trial will evaluate AB-729, an RNAi therapy in combination with VTP-300, an immunotherapeutic, and NA therapy WARMINSTER, Pa. and OXFORD, U.K., June 06,...

ABUS : 3.20 (+0.47%)
VACC : 5.00 (+11.36%)
Vaccitech to Present at the H.C. Wainwright Global Investment Conference

OXFORD, United Kingdom, May 20, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the...

VACC : 5.00 (+11.36%)

Business Summary

Vaccitech plc is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Vaccitech plc is based in OXFORD, United Kingdom.

See More

Key Turning Points

3rd Resistance Point 6.13
2nd Resistance Point 5.61
1st Resistance Point 5.31
Last Price 5.00
1st Support Level 4.49
2nd Support Level 3.97
3rd Support Level 3.67

See More

52-Week High 5.10
Last Price 5.00
Fibonacci 61.8% 3.78
Fibonacci 50% 3.37
Fibonacci 38.2% 2.96
52-Week Low 1.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Master Swing Trading: Strategies for Momentum and Trends